Omicron JN.1 Variant Raises Global Concern with Increased Animal Infectivity and Immune Evasion

The Omicron JN.1 variant shows enhanced immune evasion and a worrying potential for reverse zoonotic transmission to animals, raising the risk of viral reservoirs and future outbreaks.

A New Viral Threat: JN.1 Isn’t Just a Human Problem

As the world monitors COVID-19’s lingering threat, scientists have flagged the Omicron JN.1 variant as particularly concerning—not just for its ability to evade immunity but also for its capacity to infect a wide range of animals, suggesting the virus could jump from humans back into wildlife and livestock.

A newly published study in iScience reveals that JN.1 has a significantly higher reverse zoonotic transmission potential than earlier variants like BA.2.86, posing a serious public health risk through the establishment of new animal reservoirs.

Key Mutation Behind the Surge: L455S

The researchers identified a single amino acid substitution—L455S in the spike (S) protein—as a critical driver behind the increased infectivity and immune escape of JN.1:

Decreases spike protein stability, making it more prone to trigger fusion and entry.
Increases fusogenicity, enabling more effective infection of host cells.
Enhances immune evasion, weakening the protective effects of prior infection or vaccination.

Strikingly, individuals previously infected with Omicron subvariants (e.g., BA.5/BF.7) showed little to no neutralizing activity against JN.1, unless they had a breakthrough infection with XBB—highlighting serious gaps in current population-level immunity.

Cross-Species Concern: More Animals at Risk

The team evaluated the infectivity of JN.1 in human cells and 27 animal ACE2 receptors—from domestic pets like dogs and cats to wildlife such as squirrels, deer mice, and bats. Their findings:

Rodents, civets, and foxes exhibited high susceptibility to JN.1.
Infectivity was 7.4x higher in mouse ACE2 compared to the original Wuhan strain.
JN.1 displayed greater fusogenicity and replication than BA.2.86 across 14 animal models.
This suggests a real risk of human-to-animal transmission, known as reverse zoonosis.

“The broad host range and high infectivity of JN.1 could establish viral reservoirs in animals, increasing the chance of new variants evolving unnoticed,” said Dr. Zhaohui Qian, co-author of the study.

Not Just a Mutation—A Mechanism of Concern

While the L455S mutation reduces receptor binding affinity in some species (e.g., chickens), it enhances infectivity and immune escape across most mammals. This implies a shift in viral strategy: infect more broadly, evade immune detection, and adapt to multiple hosts.

JN.1 viruses were more thermally unstable—but more fusogenic.
They triggered stronger syncytia formation, aiding rapid spread between cells.
Live virus assays confirmed increased viral replication in multiple species.

Vaccine Implications: Time to Update Formulations?

Current vaccines may not offer sufficient protection against JN.1. The study found that XBB breakthrough infections significantly improved neutralizing antibodies against JN.1, suggesting that including XBB antigens in next-generation vaccines could help broaden immunity.

Why It Matters

Animal reservoirs = hidden pandemic potential. If JN.1 establishes itself in wild or domestic animal populations, it could re-emerge in humans with new mutations.
L455S mutation = evolutionary advantage. Its combination of high infectivity and immune evasion makes JN.1 a leading candidate for future variants of concern.
Vaccine mismatch = vulnerability. The study urges for enhanced surveillance and updated immunization strategies.

The Omicron JN.1 variant shows enhanced immune evasion and a worrying potential for reverse zoonotic transmission.

TL;DR

The Omicron JN.1 variant shows alarming signs of increased infectivity in animals and strong immune evasion in humans. A key mutation (L455S) may allow the virus to spread more efficiently and evade current vaccine protection. Surveillance and vaccine reformulation are urgently needed.

Reference:

Hu, J., Zan, F., He, Y., Ou, X., Tang, X., Liu, Y., … & Qian, Z. (2025). Enhanced reverse zoonotic potential and immune evasion by omicron JN. 1 variant. iScience. 10.1016/j.isci.2025.112824